Prevention of Postoperative Nausea and Vomiting with Granisetron and Dolasetron in Relation to CYP2D6 Genotype
Anesth Analg 2006 102: 1127-1133.
[Abstract]
[Full Text]
[PDF]
IMPLICATIONS: Administration of granisetron, 1 mg IV, and dolasetron, 12.5 mg IV, was equally effective in preventing postoperative nausea and vomiting in the postanesthesia care unit. Administration of granisetron achieved a more frequent complete response rate in the 24-h postdischarge period than administration of dolasetron. In subjects receiving dolasetron, carriers of the duplication of the CYP2D6 allele predicting ultrarapid metabolizer status had more vomiting episodes than patients in the granisetron group.